Lipella Pharmaceuticals Statistics

Total Valuation

LIPO has a market cap or net worth of 7.37 million. The enterprise value is 3.17 million.

Market Cap	7.37M
Enterprise Value	3.17M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

LIPO has 4.47 million shares outstanding. The number of shares has increased by 67.07% in one year.

Current Share Class	4.47M
Shares Outstanding	4.47M
Shares Change (YoY)	+67.07%
Shares Change (QoQ)	+69.99%
Owned by Insiders (%)	6.53%
Owned by Institutions (%)	2.38%
Float	4.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.18
PB Ratio	1.81
P/TBV Ratio	1.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.62
EV / Sales	6.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.01.

Current Ratio	6.21
Quick Ratio	5.55
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -154.54% and return on invested capital (ROIC) is -95.70%.

Return on Equity (ROE)	-154.54%
Return on Assets (ROA)	-81.17%
Return on Invested Capital (ROIC)	-95.70%
Return on Capital Employed (ROCE)	-127.25%
Revenue Per Employee	86,644
Profits Per Employee	-855,163
Employee Count	7
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.69% in the last 52 weeks. The beta is 0.46, so LIPO's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-53.69%
50-Day Moving Average	2.60
200-Day Moving Average	2.91
Relative Strength Index (RSI)	26.71
Average Volume (20 Days)	47,806

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.20

Income Statement

In the last 12 months, LIPO had revenue of 519,867 and -5.13 million in losses. Loss per share was -3.85.

Revenue	519,867
Gross Profit	-3.24M
Operating Income	-5.19M
Pretax Income	-5.13M
Net Income	-5.13M
EBITDA	-5.19M
EBIT	-5.19M
Loss Per Share	-3.85

Full Income Statement

Balance Sheet

The company has 4.23 million in cash and 23,997 in debt, giving a net cash position of 4.20 million or 0.94 per share.

Cash & Cash Equivalents	4.23M
Total Debt	23,997
Net Cash	4.20M
Net Cash Per Share	0.94
Equity (Book Value)	4.08M
Book Value Per Share	1.60
Working Capital	4.05M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-998.47%
Pretax Margin	-986.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LIPO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.07%
Shareholder Yield	n/a
Earnings Yield	-69.61%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2024. It was a reverse split with a ratio of 0.125.

Last Split Date	Nov 8, 2024
Split Type	Reverse
Split Ratio	0.125

Scores

LIPO has an Altman Z-Score of -4.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.05
Piotroski F-Score	3